Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening
Primaquine for radical cure of <i>Plasmodium vivax</i> malaria poses a potentially life-threatening risk of haemolysis in G6PD-deficient patients. Herein, we review five events of acute haemolytic anaemia following the administration of primaquine in four malaria trials from Indonesia, t...
Main Authors: | Ayleen Kosasih, Robert James, Nguyen Hoang Chau, Michelle M. Karman, Lydia Visita Panggalo, Lyndes Wini, Ngo Viet Thanh, Thomas Obadia, Ari Winasti Satyagraha, Puji Budi Setia Asih, Din Syafruddin, Walter R. J. Taylor, Ivo Mueller, Inge Sutanto, Harin Karunajeewa, Ayodhia Pitaloka Pasaribu, J. Kevin Baird |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/12/9/1176 |
Similar Items
-
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
by: Germana Bancone, et al.
Published: (2021-03-01) -
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
by: Sara Avalos, et al.
Published: (2018-11-01) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Cindy S. Chu, et al.
Published: (2018-03-01) -
Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report
by: Deepali Savargaonkar, et al.
Published: (2017-01-01) -
Modelling primaquine-induced haemolysis in G6PD deficiency
by: James Watson, et al.
Published: (2017-02-01)